Results 11 to 20 of about 3,641,147 (222)

‘Sometimes we just have to trust our gut feeling and hope the reporting is good’. [PDF]

Tidsskrift for Omsorgsforskning, 2021
Objective: Pro re nata (as needed) medications are widely used among older patients in long-term care. Current knowledge of healthcare providers’ administration of these medications and the decisions involving these medications is scarce and mainly ...
Marianne Kollerøs Nilsen, Hege Sletvold, Rose Mari Olsen   +2 more
doaj   +2 more sources

Impact of psychotropic pro re nata prescription-monitoring programme on prescriptions for inpatients with psychiatric disorders: a retrospective observational study [PDF]

BMC Psychiatry
Background Pro re nata (PRN) medication is used “as needed” for symptoms such as agitation and insomnia, in addition to regular daily pharmacotherapy of mental disorders. However, there is no high-quality evidence on the effectiveness of psychotropic PRN
Yoshitaka Saito, Kyohei Sumida, Hiroyuki Muraoka, Satoru Oishi, Ryutaro Suzuki, Taiyo Nishikawa, Shin Miyake, Yukihiro Tanno, Yuki Tobita, Katsuya Otori, Ken Inada   +10 more
doaj   +2 more sources

Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema [PDF]

GMS Ophthalmology Cases, 2020
Aims: To evaluate treatment outcomes of pro re nata dosing of intravitreal dexamethasone implant in eyes with refractory diabetic macular edema (DME) amongst Indian subjects.Methods and material: Retrospective, interventional case series. Medical records
Rishi, Pukhraj, Rishi, Ekta, Attiku, Yamini, Dhami, Abhinav, Iyer, Vandana   +4 more
doaj   +2 more sources

Potentially Inappropriate Medication Use among Nursing Home Residents: Medication Errors Associated with Pro re nata Medications and the Importance of Pill Burden [PDF]

Annals of Geriatric Medicine and Research, 2022
Background The use of potentially inappropriate medications (PIM) has become more common among nursing home residents (NHR). This study focused on drugs initially prescribed as pro re nata (PRN) medications and pill burden in association with PIM among ...
Fatma Özge Kayhan Koçak, Emin Taşkıran, Zehra Kosuva Öztürk, Sevnaz Şahin   +3 more
doaj   +2 more sources

Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice [PDF]

Ophthalmology and Therapy
Introduction Anti-vascular endothelial growth factor (VEGF) is generally given using pro re nata or “treat-and-extend” (T&E) regimens for neovascular age-related macular degeneration (nAMD).
Eloi Debourdeau, Helene Beylerian, Vuong Nguyen, Daniel Barthelmes, Mark Gillies, Pierre Henry Gabrielle, Stela Vujosevic, Louise Otoole, Martin Puzo, Catherine Creuzot-Garcher, Benjamin Wolff, Vincent Daien, The Fight Retinal Blindness! Study Group   +12 more
doaj   +2 more sources

Prevalence and types of medication errors in pro re nata medication orders among hospitalized patients: a cross-sectional study [PDF]

Journal of Pharmaceutical Health Care and Sciences
Background Medication errors in Pro Re Nata (PRN) prescriptions pose a significant threat in hospital settings, especially due to unclear prescribing practices.
Arefeh Rasouli-Rad, Mahdi Ahmadinia, Azadeh Eshraghi, Hamidreza Aslani, Zahra Karimian, Akram Hashemi, Maryam Farasatinasab   +6 more
doaj   +2 more sources

Non-pharmacological alternatives to pro re nata psychotropic medication

, 2021
Pro re nata (as-required) psychotropic medicines are used frequently in mental health settings; however, concerns have been raised over the safety and lack of evidence of effectiveness of this practice.
Pickup, Jaclyn, Price, Owen; id_orcid
core   +10 more sources

Two-year outcomes of pro re nata ranibizumab monotherapy for exudative age-related macular degeneration in Japanese patients

Clinical Ophthalmology, 2013
Akiko Yamamoto,1 Annabelle A Okada,1 Atsuhiko Sugitani,1,2 Daisuke Kunita,1 Tosho Rii,1 Reiji Yokota1 1Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan; 2Department of Ophthalmology, Kugayama Hospital, Tokyo, Japan Purpose:
Yamamoto A, Okada AA, Sugitani A, Kunita D, Rii T, Yokota R   +5 more
doaj   +1 more source

One-Year Outcomes of Aflibercept in Treat-and-Extend Versus Pro Re Nata Regimens for Bevacizumab-Resistant Diabetic Macular Edema: A Real-World Study [PDF]

Ophthalmology and Therapy
Introduction The aim of this study was to compare the efficacy of the treat-and-extend (TAE) regimen versus the pro re nata (PRN) regimen in patients with bevacizumab-resistant diabetic macular edema (DME) treated with aflibercept, with or without ...
Zubeyir Yozgat, Mehmed Ugur Isik, Mehmet Cem Sabaner   +2 more
doaj   +2 more sources

‘To give or not to give medication, that is the question.’ Healthcare personnel’s perceptions of factors affecting pro re nata medication in sheltered housing for older adults — a focus-group interview study [PDF]

BMC Health Services Research, 2020
Background Residents living in sheltered housing depend on help from healthcare personnel (HCP) with medication management, regarding regular long-term and pro re nata (PRN) medication.
Marianne Kollerøs Nilsen, Hege Sletvold, Rose Mari Olsen   +2 more
doaj   +2 more sources